Furthermore, a lower CASTOR1 expression level (Supplementary Fig. 7f, g) and a higher RNF167 expression level (Supplementary Fig. 7h, i) were correlated with poor survival in ER+ and HER2+ breast cancer, respectively. The gene discussed is ERBB2; the disease is breast carcinoma.